Hunt Anthony
SEC insider (Form 3/4/5 filer). CIK 0001606030. Director at BIOLIFE SOLUTIONS INC (BLFS) and 2 other issuers. 58 reported Form 4/5 transactions since Sep 2024; latest on Oct 6, 2026. Located in BOTHELL, WA.
Companies Hunt Anthony has filed insider reports for
- BIOLIFE SOLUTIONS INC (BLFS): Director
- 908 Devices Inc. (MASS): Director
- REPLIGEN CORP (RGEN): Director
Hunt Anthony
CIK: 0001606030
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (58 total)
- Oct 6, 2026BLFS
BIOLIFE SOLUTIONS INC
DispositionDirect15K shares- - Jun 11, 2026MASS
908 Devices Inc.
AwardDirectStock Option (option to buy)
6.2K shares- - Jun 11, 2026MASS
908 Devices Inc.
AwardDirectRestricted Stock Units
13.7K shares- - Jun 10, 2026MASS
908 Devices Inc.
ExerciseDirect14.1K shares- - Mar 2, 2026RGEN
REPLIGEN CORP
Tax PaymentDirect9.9K shares at avg. $124.97$1.2M - Feb 24, 2026BLFS
BIOLIFE SOLUTIONS INC
AwardDirect8.2K shares- - Dec 4, 2025RGEN
REPLIGEN CORP
OtherDirect2K shares- - Nov 13, 2025RGEN
REPLIGEN CORP
SaleDirect2K shares at avg. $157.11$307K - Nov 13, 2025RGEN
REPLIGEN CORP
SaleDirect5.7K shares at avg. $156.22$896K - Nov 13, 2025RGEN
REPLIGEN CORP
ExerciseDirect3K shares at avg. $33.87$100K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 6, 2026 |  BLFS BIOLIFE SOLUTIONS INC | Disposition | 15,046 | - | $0 | Direct |
| Jun 11, 2026 |  MASS 908 Devices Inc. | Award Stock Option (option to buy) | 6,209 | - | - | Direct |
| Jun 11, 2026 | MASS 908 Devices Inc. | Award Restricted Stock Units | 13,656 | - | - | Direct |
| Jun 10, 2026 | MASS 908 Devices Inc. | Exercise | 14,083 | - | $0 | Direct |
| Mar 2, 2026 |  RGEN REPLIGEN CORP | Tax Payment | 9,897 | $124.97 | $1,236,828 | Direct |
| Feb 24, 2026 | BLFS BIOLIFE SOLUTIONS INC | Award | 8,170 | - | $0 | Direct |
| Dec 4, 2025 | RGEN REPLIGEN CORP | Other | 2,000 | - | - | Direct |
| Nov 13, 2025 | RGEN REPLIGEN CORP | Sale | 1,956 | $157.11 | $307,307 | Direct |
| Nov 13, 2025 | RGEN REPLIGEN CORP | Sale | 5,737 | $156.22 | $896,234 | Direct |
| Nov 13, 2025 | RGEN REPLIGEN CORP | Exercise | 2,952 | $33.87 | $99,984 | Direct |
1-10 of 58 transactions